3 results
Approved WMOCompleted
To compare the effect of semaglutide 1.0 mg once-weekly versus exenatide extended release (ER) 2.0 mg once-weekly on glycaemic control after 56 weeks of treatment.
Approved WMOCompleted
Primary Objective:To assess Laser Detection Rates of A* and C nerve fibers in healthy study subjects.Secondary Objectives:To assess Reaction Time after selective stimulation of A* and C nerve fibers in healthy subjects
Approved WMOCompleted
Primary purpose: study the feasibility of a new treatment option based on biofeedback in people with intellectual disabilities.Secondary purpose: explore effects of treatment for swallowing problems in people with intellectual disabilities.